Mechanistic insights and the clinical prospects of targeted therapies for glioblastoma: a comprehensive review
Glioblastoma (GBM) is a fatal brain tumour that is traditionally diagnosed based on
histological features. Recent molecular profiling studies have reshaped the World Health …
histological features. Recent molecular profiling studies have reshaped the World Health …
Lessons from anti–vascular endothelial growth factor and anti–vascular endothelial growth factor receptor trials in patients with glioblastoma
Treatment of glioblastoma (GBM), the most common primary malignant brain tumor in adults,
remains a significant unmet need in oncology. Historically, cytotoxic treatments provided …
remains a significant unmet need in oncology. Historically, cytotoxic treatments provided …
Incidence and management of olaratumab infusion-related reactions
BA Van Tine, R Govindarajan, S Attia… - Journal of oncology …, 2019 - ascopubs.org
PURPOSE: Olaratumab is a human monoclonal immunoglobulin G1 antibody against
platelet-derived growth factor receptor-α. We report the nature and frequency of infusion …
platelet-derived growth factor receptor-α. We report the nature and frequency of infusion …
[PDF][PDF] Characterization of Angiogenesis-Related Molecules in Glioblastoma: potential application as biomarkers for bevacizumab-based therapy
BMF de Carvalho - 2022 - repositorio-aberto.up.pt
Após anos de investigação, o prognóstico do glioblastoma (GBM) permanece ominoso. A
temozolomida (TMZ) associada à radioterapia permitiu alcançar uma sobrevivência global …
temozolomida (TMZ) associada à radioterapia permitiu alcançar uma sobrevivência global …